A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL). (Q45129280)
Jump to navigation
Jump to search
scientific article published in November 2004
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL). |
scientific article published in November 2004 |
Statements
1 reference
A pilot trial of rituximab and alemtuzumab combination therapy in patients with relapsed and/or refractory chronic lymphocytic leukemia (CLL). (English)
1 reference
1 reference
Martin S Tallman
1 reference
Chadi Nabhan
1 reference
David Patton
1 reference
Mary B Riley
1 reference
Timothy Kuzel
1 reference
Steven T Rosen
1 reference
1 November 2004
1 reference
1 reference
45
1 reference
11
1 reference
2269-2273
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
1 reference
Identifiers
1 reference
1 reference